Clinical Trial

Affect of Duavive on Mood & Anxiety Symptoms

Study acronym: DOMA
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the impact of conjugated estrogens/ bazedoxifene (CE/ BZA) on the mood (depression and anxiety) in peri- and early menopausal women.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-07-15; most recent amendment 2024-11-28.
Status change: Not Yet Recruiting → Recruiting 2024-11-28
Trial Details
NCT Number NCT04478305
Lead Sponsor St. Joseph's Healthcare Hamilton
Collaborators: McMaster University, Pfizer
Conditions Menopause, Depression, Anxiety, Sleep, Menopause Related Conditions
Enrollment 30 participants
Start Date 2024-07-03
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-03